Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Acquisition of a second multi-drug resistance-encoding element by IncM1 plasmid pACM130 abolished conjugative transfer.

Preston KE, Tine JA.

Plasmid. 2017 Jul;92:26-29. doi: 10.1016/j.plasmid.2017.05.003. Epub 2017 May 30.

PMID:
28571994
2.

[Evaluation of microalbuminuria and lipid profile among type 2 diabetics].

Diouf NN, Lo G, Sow-Ndoye A, Djité M, Tine JA, Diatta A.

Rev Med Brux. 2015 Jan-Feb;36(1):10-3. French.

PMID:
25856966
3.

The complete nucleotide sequence of the multi-drug resistance-encoding IncL/M plasmid pACM1.

Preston KE, Hitchcock SA, Aziz AY, Tine JA.

Plasmid. 2014 Nov;76:54-65. doi: 10.1016/j.plasmid.2014.08.005. Epub 2014 Oct 5.

PMID:
25291385
4.

Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Avasarala JR, Chittur SV, George AD, Tine JA.

BMC Med Genomics. 2008 Jan 31;1:2. doi: 10.1186/1755-8794-1-2.

5.

New cytochrome P450 2D6*56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes.

Li L, Pan RM, Porter TD, Jensen NS, Silber P, Russo G, Tine JA, Heim J, Ring B, Wedlund PJ.

Drug Metab Dispos. 2006 Aug;34(8):1411-6. Epub 2006 May 5.

PMID:
16679388
6.

Global gene expression profiles associated with retinoic acid-induced differentiation of embryonal carcinoma cells.

Eifert C, Sangster-Guity N, Yu LM, Chittur SV, Perez AV, Tine JA, McCormick PJ.

Mol Reprod Dev. 2006 Jul;73(7):796-824.

PMID:
16604517
7.

Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.

Tine JA, Firat H, Payne A, Russo G, Davis SW, Tartaglia J, Lemonnier FA, Demoyen PL, Moingeon P.

Vaccine. 2005 Jan 11;23(8):1085-91.

PMID:
15620483
8.

Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.

Rogers WO, Weiss WR, Kumar A, Aguiar JC, Tine JA, Gwadz R, Harre JG, Gowda K, Rathore D, Kumar S, Hoffman SL.

Infect Immun. 2002 Aug;70(8):4329-35.

9.

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.

Rogers WO, Baird JK, Kumar A, Tine JA, Weiss W, Aguiar JC, Gowda K, Gwadz R, Kumar S, Gold M, Hoffman SL.

Infect Immun. 2001 Sep;69(9):5565-72.

10.

ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques.

Kumar A, Weiss W, Tine JA, Hoffman SL, Rogers WO.

J Immunol Methods. 2001 Jan 1;247(1-2):49-60.

PMID:
11150536
11.

Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.

Sutmuller RP, Schurmans LR, van Duivenvoorde LM, Tine JA, van Der Voort EI, Toes RE, Melief CJ, Jager MJ, Offringa R.

J Immunol. 2000 Dec 15;165(12):7308-15.

12.

In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.

Hedstrom RC, Doolan DL, Wang R, Kumar A, Sacci JB Jr, Gardner MJ, Aguiar JC, Charoenvit Y, Sedegah M, Tine JA, Margalith M, Hobart P, Hoffman SL.

Int J Mol Med. 1998 Jul;2(1):29-38.

PMID:
9854139
13.

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.

Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, Tine JA, Hoffman SL.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7648-53.

14.

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al.

J Infect Dis. 1998 Jun;177(6):1664-73.

PMID:
9607847
15.

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Tine JA, Lanar DE, Smith DM, Wellde BT, Schultheiss P, Ware LA, Kauffman EB, Wirtz RA, De Taisne C, Hui GS, Chang SP, Church P, Hollingdale MR, Kaslow DC, Hoffman S, Guito KP, Ballou WR, Sadoff JC, Paoletti E.

Infect Immun. 1996 Sep;64(9):3833-44.

16.

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR, Paoletti E, Sadoff JC.

Infect Immun. 1996 May;64(5):1666-71.

17.

HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.

Wizel B, Houghten R, Church P, Tine JA, Lanar DE, Gordon DM, Ballou WR, Sette A, Hoffman SL.

J Immunol. 1995 Jul 15;155(2):766-75.

PMID:
7541824
18.

Live attenuated vaccinia and other poxviruses as delivery systems: public health issues.

Perkus ME, Taylor J, Tartaglia J, Pincus S, Kauffman EB, Tine JA, Paoletti E.

Ann N Y Acad Sci. 1995 May 31;754:222-33. No abstract available.

PMID:
7625655
19.

Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2.

Wizel B, Rogers WO, Houghten RA, Lanar DE, Tine JA, Hoffman SL.

Eur J Immunol. 1994 Jul;24(7):1487-95.

PMID:
7517870
20.

Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Tine JA, Conseil V, Delplace P, De Taisne C, Camus D, Paoletti E.

Infect Immun. 1993 Sep;61(9):3933-41.

21.

Genetic polymorphisms of Q region genes from wild-derived mice: implications for Q region evolution.

Tine JA, Walsh A, Rathbun D, Leonard L, Wakeland EK, Dilwith R, Flaherty L.

Immunogenetics. 1990;31(5-6):315-25.

PMID:
2370077
22.

Immunogenetics of the Q and TL regions of the mouse.

Flaherty L, Elliott E, Tine JA, Walsh AC, Waters JB.

Crit Rev Immunol. 1990;10(2):131-75. Review. No abstract available.

PMID:
2076187

Supplemental Content

Support Center